Suncity Synthetics Limited has formally notified BSE about its upcoming board meeting to deliberate on significant fund raising initiatives. The company has issued an official intimation under regulatory compliance requirements, outlining its strategic approach to address funding requirements through various financial instruments.

Board Meeting Schedule

The board meeting has been scheduled with specific parameters and objectives outlined in the official communication to BSE.

Fund Raising Strategy

The primary agenda focuses on the company's decision to pursue preferential issue of shares to meet its funding requirements. The board will consider multiple financing options to strengthen the company's capital structure and address the fund requirement in the company.

The proposed fund raising mechanisms include:

• Issuance of equity shares or equity linked instruments
• Convertible loans and other securities
• Convertible preference shares
• Fully or partially convertible debentures
• Composite issue of non-convertible debentures and warrants
• Qualified Institutions Placement
• Further public issue of debt or equity securities
• Preferential issue or Right issue
• Any other permissible mode and combinations thereof

Regulatory Compliance Framework

The fund raising initiatives will be conducted in accordance with established regulatory guidelines. The company has emphasized compliance with the Securities and Exchange Board of India (Issue of Capital and Disclosures Requirements) Regulations, 2018, and provisions of the Companies Act, 2013.

The board will evaluate various combinations of these funding options to determine the most appropriate approach for the company's specific requirements. The meeting will also address any additional items that the Board of Directors may decide to discuss.

Corporate Communication

The formal intimation dated March 14, 2026, was signed by Sumita Mishra, Managing Director (DIN: 00207928) of Suncity Synthetics Limited, and communicated to the Department of Corporate Relations at BSE Limited. The notification ensures transparency and regulatory compliance in the company's fund raising process.

Suncity Synthetics Limited has announced the approval of its unaudited financial results for the third quarter of fiscal year 2026, following a board meeting held on February 14, 2026. The company conducted the meeting in compliance with regulatory requirements under SEBI listing obligations.

Board Meeting Details

The board meeting took place at the company's registered office located at B-129 Ansa Industrial Estate, Sakinaka Andheri East, Mumbai. The meeting was convened to address regulatory compliance under Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Results Approval

The board considered and approved the unaudited financial results for the quarter and nine months ended December 31, 2025. The approval included the limited review report accompanying the financial statements, ensuring compliance with regulatory disclosure requirements.

Corporate Information

Suncity Synthetics Limited operates under CIN L17110MH1988PLC454234 and trades on BSE with code 530795. The company's Managing Director Sumita Mishra, holding DIN 00207928, digitally signed the regulatory filing on February 14, 2026.

The company maintains its registered office in Mumbai's Andheri East area and can be contacted through multiple channels including email at suncitysyntheticslimited@gmail.com and their official website. The regulatory filing demonstrates the company's commitment to maintaining transparency and compliance with stock exchange requirements for quarterly financial disclosures.